Transcriptional up-regulation of restin by all-trans retinoic acid through STAT1 in cancer cell differentiation process

Biochemical and Biophysical Research Communications

Volumn 343, Issue 4, 2006, Pages 1009-1016

  Fu, Haiyan ^a   Yang, Guodong ^a   Lu, Fan ^a   Wang, Ruihua ^a   Yao, Libo ^a   Lu, Zifan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

All trans retinoic acid; Cancer; Luciferase reporter; Promoter; restin; STAT1

Indexed keywords

RESTIN; RETINOIC ACID; STAT1 PROTEIN;

ANALYTIC METHOD; ARTICLE; CANCER CELL; CELL ACTIVITY; CELL DIFFERENTIATION; CLONING VECTOR; CONTROLLED STUDY; DNA FLANKING REGION; GENE DELETION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE BINDING SITE; OBSERVATION; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; UPREGULATION;

ANTIGENS, NEOPLASM; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE, TUMOR; HUMANS; INTERFERON-STIMULATED GENE FACTOR 3; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRETINOIN; UP-REGULATION;

ATRA; MINK CELL FOCUS-FORMING VIRUS;

EID: 33646049052     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.02.176     Document Type: Article

References (22)

1. Chomez P., De Backer O., Bertrand M., et al. An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res. 61 (2001) 5544-5551
2. Barker P.A., and Salehi A. The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J. Neurosci. Res. 67 (2002) 705-712
3. Chiba T., Yokosuka O., Kanda T., Fukai K., Imazeki F., Saisho H., Nishimura M., and Saito Y. Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid. Liver 22 (2002) 514-527
4. Zhao Z.L., Lu F., Zhu F., Yang H., Chai Y.B., and Chen S.M. Cloning and biological comparison of Restin, a novel member of Mage superfamily. Sci. Chin. Ser. C. 45 (2002) 412-420
5. Taniura H., Taniguchi N., Hara M., and Yoshikawa K. Necdin, a postmitotic neuron-specific growth suppressor, interacts with viral transforming proteins and cellular transcription factor E2F1. J. Biol. Chem. 273 (1998) 720-728
6. Taniura H., Matsumoto K., and Yoshikawa K. Physical and functional interactions of neuronal growth suppressor necdin with p53. J. Biol. Chem. 274 (1999) 16242-16248
7. Salehi A.H., Roux P.P., Kubu C.J., Zenindler C., Bhakar A., Tannis L.L., Verdi J.M., and Barker P.A. NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis. Neuron. 27 (2000) 279-288
8. Xiao J.H., Durand B., Chambon P., and Voorhees J.J. Endogenous retinoic acid receptor (RAR)-retinoid X receptor (RXR) heterodimers are the major functional forms regulating retinoid-responsive elements in adult human keratinocytes. Binding of ligands to RAR only is sufficient for RAR-RXR heterodimers to confer ligand-dependent activation of hRAR beta 2/RARE (DR5). J. Biol. Chem. 270 (1995) 3001-3011
9. Mader S., Chen J.Y., Chen Z., White J., Chambon P., and Gronemeyer H. The patterns of binding of RAR, RXR, and TR homo- and heterodimers to direct repeats are dictated by the binding specificities of the DNA binding domains. EMBO J. 12 (1993) 5029-5041
10. Kurokawa R., DiRenzo J., Boelun M., Sugarman J., Gloss B., Rosenfeld M.G., Heyman R.A., and Glass C.K. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature 371 (1994) 528-531
11. Park E.Y., Dillard A., Williams E.A., Wilder E.T., Pepper M.R., and Lane M.A. Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism. Cancer Res. 65 (2005) 9923-9933
12. Shang Y., Baumrucker C.R., and Green M.H. The induction and activation of STAT1 by all-trans-retinoic acid are mediated by RARβ signaling pathways in breast cancer cells. Oncogene 18 (1999) 6725-6732
13. Gille J., Paxton L.L., Lawley T.J., Caughman S.W., and Swerlick R.A. Retinoic acid inhibits the regulated expression of vascular cell adhesion molecule-1 by cultured dermal microvascular endothelial cells. J. Clin. Invest. 99 (1997) 492-500
14. Bastien J., and Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328 (2004) 1-16
15. Bastine J., Adam-Stitah S., Plassat J.L., Chambon P., and Rochette-Egly C. The phosphorylation site located in the A region of RXRa is required for the anti-proliferative effect of retinoic acid and the activation of RA-target genes in F9 cells. J. Biol. Chem. 277 (2002) 28683-28689
16. Cao Z., Flanders K.C., Bertolette D., Lyakh L.A., Wurthner J.U., Parks W.T., Letterio J.J., Ruscetti F.W., and Roberts A.B. Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-beta and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells. Blood 101 (2003) 498-507
17. Sarkar S.A., and Sharma R.P. All-trans-retinoic acid-mediated modulation of p53 during neural differentiation in murine embryonic stem cells. Cell Biol. Toxicol. 18 (2002) 243-257
18. Clarke N., Jimenez-Lara A.M., Voltz E., and Gronemeyer H. Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL. EMBO J. 23 (2004) 3051-3060
19. Osterlund C., Tohomen V., Forslund K.O., and Nordqvist K. Mage-b4, a novel melanoma antigen(MAGE)gene specifically expressed during germ cell differentiation. Cancer Res. 60 (2002) 1054-1061
20. Maruyama K., Usami M., Aizawa T., and Yoshikawa K. A novel brain specific mRNA encoding nuclear protein(necdin) expressed in neurally differentiated embryonal carcinoma cells. Biochem. Biophys. Res. Commun. 178 (1991) 291-296
21. Wu Y.S., Lu F., Qi Y.X., Wang R.H., Zhang J., Lu Z.F., and Zhao Z.L. Interaction of Restin with transcription factors. Sci. Chin. Ser. C. 48 (2005) 256-262
22. Stephanou A., and Latchman D.S. Opposing actions of STAT-1 and STAT-3. Growth Factors 23 (2005) 177-182